The U.S. Department of Health and Human Services (HHS) is re-evaluating its stance on fluoride in drinking water by reconvening the Community Preventive Services Task Force, an independent panel of health experts. This move follows Health Secretary Robert F. Kennedy Jr.’s recent statement in Salt Lake City, indicating plans to halt the Centers for Disease Control and Prevention’s recommendation for community water fluoridation.
Fluoride, commonly added to public water supplies to prevent tooth decay, has been a controversial topic for decades. While the American Dental Association continues to support fluoridation as an effective dental health measure, concerns about potential health risks have gained traction.
The Environmental Protection Agency (EPA) will also review new scientific data on fluoride’s health effects. EPA Administrator Lee Zeldin confirmed that this effort is in collaboration with HHS, with the goal of re-evaluating the agency’s current enforceable fluoride limit of 4.0 milligrams per liter (mg/L). Currently, the U.S. Public Health Service recommends maintaining levels below 0.7 mg/L. Studies show that exposure above 1.5 mg/L can increase risks of bone fractures, thyroid dysfunction, and neurological damage.
In a landmark move, Utah became the first state to ban fluoride in public water systems after Governor Spencer Cox signed new legislation last month. The decision faced strong opposition from health experts and organizations, including the American Dental Association.
As of 2022, about 63% of Americans receive fluoridated water through their municipal systems. A 2024 federal court ruling ordered the EPA to tighten its standards, citing unacceptable health risks to children under current fluoride levels. While Kennedy claims links between fluoride and conditions like cancer, his statements remain unsubstantiated by definitive scientific evidence.


U.S. Government Enters Brief Shutdown as Congress Delays Funding Deal
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Putin Envoy Kirill Dmitriev to Visit Miami for Talks With Trump Administration Officials
Israel Intensifies Gaza Airstrikes Amid Ceasefire Tensions
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Laura Fernandez Set to Become Costa Rica’s Next President, Promising Sweeping Political Change
Trump Says Fed Pick Kevin Warsh Could Win Democratic Support in Senate Confirmation
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Venezuela Proposes Amnesty Law and Plans to Transform Helicoide Prison
Trump Proposes Two-Year Shutdown of Kennedy Center Amid Ongoing Turmoil
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis 



